Faull RJ - Search Results

1

L-carnitine supplementation in the dialysis population: are Australian patients missing out?

Reuter SE, Faull RJ, Evans AM. Reuter SE, et al. Among authors: faull rj. Nephrology (Carlton). 2008 Feb;13(1):3-16. doi: 10.1111/j.1440-1797.2007.00817.x. Nephrology (Carlton). 2008. PMID: 18199095 Review.

2

Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.

Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL. Evans AM, et al. Clin Pharmacol Ther. 2000 Sep;68(3):238-49. doi: 10.1067/mcp.2000.108850. Clin Pharmacol Ther. 2000. PMID: 11014405

3

Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.

Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, Fornasini G. Evans AM, et al. Among authors: faull rj. Kidney Int. 2004 Oct;66(4):1527-34. doi: 10.1111/j.1523-1755.2004.00916.x. Kidney Int. 2004. PMID: 15458447 Free article.

4

Quantifying trimethylamine and trimethylamine-N-oxide in human plasma: interference from endogenous quaternary ammonium compounds.

Bain MA, Faull R, Fornasini G, Milne RW, Schumann R, Evans AM. Bain MA, et al. Anal Biochem. 2004 Nov 15;334(2):403-5. doi: 10.1016/j.ab.2004.07.004. Anal Biochem. 2004. PMID: 15494149 No abstract available.

5

Crystalloid deposits in the kidney.

Keller LS, Faull RJ, Smith P, Swift J, Bannister KM, Otto S, Peh CA. Keller LS, et al. Among authors: faull rj. Nephrology (Carlton). 2005 Feb;10(1):81-3. doi: 10.1111/j.1440-1797.2005.00290.x. Nephrology (Carlton). 2005. PMID: 15705186 Review.

6

Bad and good growth factors in the peritoneal cavity.

Faull RJ. Faull RJ. Nephrology (Carlton). 2005 Jun;10(3):234-9. doi: 10.1111/j.1440-1797.2005.00395.x. Nephrology (Carlton). 2005. PMID: 15958035 Review.

7

Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.

Reuter SE, Evans AM, Faull RJ, Chace DH, Fornasini G. Reuter SE, et al. Among authors: faull rj. Ann Clin Biochem. 2005 Sep;42(Pt 5):387-93. doi: 10.1258/0004563054889954. Ann Clin Biochem. 2005. PMID: 16168195

8

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

Bain MA, Faull R, Fornasini G, Milne RW, Evans AM. Bain MA, et al. Nephrol Dial Transplant. 2006 May;21(5):1300-4. doi: 10.1093/ndt/gfk056. Epub 2006 Jan 9. Nephrol Dial Transplant. 2006. PMID: 16401621

9

Oral L-carnitine: metabolite formation and hemodialysis.

Bain MA, Faull R, Milne RW, Evans AM. Bain MA, et al. Curr Drug Metab. 2006 Oct;7(7):811-6. doi: 10.2174/138920006778520561. Curr Drug Metab. 2006. PMID: 17073580 Clinical Trial.

10

Effect of pravastatin on markers of endothelial activation in dialysis patients.

Jeffs LS, Skilton F, Nitschke J, Bannister KM, Faull RJ. Jeffs LS, et al. Among authors: faull rj. Nephrology (Carlton). 2007 Jun;12(3):234-8. doi: 10.1111/j.1440-1797.2007.00766.x. Nephrology (Carlton). 2007. PMID: 17498117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters